Literature DB >> 321001

Selective inhibition by danazol of follicle stimulating hormone during the luteal phase.

B A Lieberman, S Thom, M A Murray, H S Jacobs.   

Abstract

In each of six healthy, normally menstruating women, serum oestradiol, progesterone, basal and post luteinizing hormone releasing hormone (LHRH) gonadotrophin measurements were made during the luteal phase of a normal cycle and in a subsequent cycle in which 800 mg of danazol was given daily from the fifth day after the presumptive date of ovulation. No differences in the serum oestradiol, progesterone, or basal gonadotrophin levels were detected, but there was a selective impairment of the follicle stimulating hormone response to LHRH. The implications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 321001     DOI: 10.1111/j.1471-0528.1977.tb12468.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  2 in total

1.  Medical management of endometriosis.

Authors: 
Journal:  Br Med J       Date:  1977-05-07

2.  Danazol in the treatment of gynaecomastia.

Authors:  R Buckle
Journal:  Drugs       Date:  1980-05       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.